Suchergebnisse - "Lu, Mingqing"

PubPharm (20)

1

Effectiveness of a broad-spectrum bivalent mRNA vaccine against SARS-CoV-2 variants in preclinical studies

enthalten in: Emerging microbes & infections | 2024

von Lu, J. | Tan, S. | Gu, H. | +18

2

Vaccines based on the fusion protein consensus sequence protect Syrian hamsters from Nipah virus infection

enthalten in: JCI insight | 2023

von Lu, M. | Yao, Y. | Liu, H. | +21

3

Both chimpanzee adenovirus-vectored and DNA vaccines induced long-term immunity against Nipah virus infection

enthalten in: NPJ vaccines | 2023

von Lu, M. | Yao, Y. | Zhang, X. | +18

4

Recombinant chimpanzee adenovirus vector vaccine expressing the spike protein provides effective and lasting protection against SARS-CoV-2 infection in mice

enthalten in: Virologica Sinica | 2022

von Lu, M. | Liu, K. | Peng, Y. | +15

5

Preparation method of nano calcium carbonate for MS sealant

enthalten in: Europäisches Patentamt | 2022

von JIN HUI | LI PENG | FAN LINTONG | +4

6

The Effect of Mobile Social Media Sharing Behavior on the Subjective Well-Being and Mental Health Regulation of Internet Users

enthalten in: Occupational therapy international | 2022

von Lu, M. | Ma, Q.

RetractionIn: Occup Ther Int. 2023 Aug 23;2023:9824591. - PMID 37664164

7

Method for preparing active nano calcium carbonate at normal temperature and high concentration

enthalten in: Europäisches Patentamt | 2021

von LI PENG | LU MINGQING | SUN HAO | +4

8

Pseudorabies virus glycoprotein gE suppresses interferon-β production via CREB-binding protein degradation

enthalten in: Virus research | 2021

von Lu, M. | Qiu, S. | Zhang, L. | +3

9

Delayed specific IgM antibody responses observed among COVID-19 patients with severe progression

enthalten in: Emerging microbes & infections | 2020

von Shen, L. | Wang, C. | Zhao, J. | +10

10

Nuclear transporter karyopherin subunit alpha 3 levels modulate Porcine circovirus type 2 replication in PK-15 cells

enthalten in: Virology | 2020

von Zhang, L. | Qiu, S. | Lu, M. | +2